A Phase 2 Study of MZE829 in Adults With APOL1 Kidney Disease
Recruiting · NCT06830629 · Interventional (participants receive a specific treatment) · Lead sponsor: Maze Therapeutics
View the official record on ClinicalTrials.gov →Interventions studied
MZE829
What this trial is about
The purpose of this study is to evaluate the safety, tolerability, and effect on Albuminuria of MZE829 in Adults with APOL1 Kidney Disease.
Who can take part
Age range
18 Years to 68 Years
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Phase 2
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- APOL1 high risk genotype of G1/G1, G2/G2, or G1/G2
- Chronic kidney disease with persistent albuminuria
- Key
Exclusion criteria
- Organ or bone marrow transplantation
- History of active cancer within past 2 years, except for treated non-melanoma skin cancer, stage 0 cervical cancer, or stage 1 prostate cancer
- Conditions that may alter drug absorption, e.g., history of bariatric surgery
- Type I diabetes
- Pregnant or currently nursing
- ther inclusion/exclusion criteria defined in protocol apply.
Where it is running
60 locations listed across 24 US states.
- Research Site - Decatur, Alabama, United States
- Research Site - Huntsville, Alabama, United States
- Research Site - Montgomery, Alabama, United States
- Research Site - Montgomery, Alabama, United States
- Research Site - Bloomfield, Connecticut, United States
- Research Site - Washington D.C., District of Columbia, United States
- Research Site - Atlantis, Florida, United States
- Research Site - Brandon, Florida, United States
- Research Site - Hollywood, Florida, United States
- Research Site - Melbourne, Florida, United States
- Research Site - Orlando, Florida, United States
- Research Site - Atlanta, Georgia, United States
- Research Site - College Park, Georgia, United States
- Research Site - Cordele, Georgia, United States
- Research Site - Macon, Georgia, United States
- Research Site - Riverdale, Georgia, United States
- Research Site - Riverdale, Georgia, United States
- Research Site - Savannah, Georgia, United States
- Research Site - Snellville, Georgia, United States
- Research Site - Chicago, Illinois, United States
- Research Site - Chicago, Illinois, United States
- Research Site - Evanston, Illinois, United States
- Research Site - Kansas City, Kansas, United States
- Research Site - Bowling Green, Kentucky, United States
- Research Site - Louisville, Kentucky, United States
- Research Site - Arnold, Maryland, United States
- Research Site - Lutherville, Maryland, United States
- Research Site - Oxon Hill, Maryland, United States
- Research Site - Dearborn, Michigan, United States
- Research Site - Flint, Michigan, United States
- Research Site - Pontiac, Michigan, United States
- Research Site - Saint Joseph, Michigan, United States
- Research Site - Minneapolis, Minnesota, United States
- Research Site - Tupelo, Mississippi, United States
- Research Site - City of Saint Peters, Missouri, United States
- Research Site - St Louis, Missouri, United States
- Research Site - Las Vegas, Nevada, United States
- Research Site - Jersey City, New Jersey, United States
- Research Site - Buffalo, New York, United States
- Research Site - Laurelton, New York, United States
- Research Site - Maspeth, New York, United States
- Research Site - Newburgh, New York, United States
- Research Site - Durham, North Carolina, United States
- Research Site - Fayetteville, North Carolina, United States
- Research Site - Greensboro, North Carolina, United States
- Research Site - Shelby, North Carolina, United States
- Research Site - Cleveland, Ohio, United States
- Research Site - Cleveland, Ohio, United States
- Research Site - Columbus, Ohio, United States
- Research Site - Ardmore, Oklahoma, United States
- Research Site - Philadelphia, Pennsylvania, United States
- Research Site - Philadelphia, Pennsylvania, United States
- Research Site - Upland, Pennsylvania, United States
- Research Site - Columbia, South Carolina, United States
- Research Site - Spartanburg, South Carolina, United States
- Research Site - Spartanburg, South Carolina, United States
- Research Site - Chattanooga, Tennessee, United States
- Research Site - Dallas, Texas, United States
- Research Site - Dallas, Texas, United States
- Research Site - Greenville, Texas, United States
Showing 60 of 79 listed sites. See the official record for the complete list.
Read the full protocol, contacts and eligibility on ClinicalTrials.gov →